Global Personalized Medicine for Cancer Supply, Demand and Key Producers, 2024-2030

Description

The global Personalized Medicine for Cancer market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global Personalized Medicine for Cancer demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Personalized Medicine for Cancer, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Personalized Medicine for Cancer that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Personalized Medicine for Cancer total market, 2019-2030, (USD Million)
Global Personalized Medicine for Cancer total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Personalized Medicine for Cancer total market, key domestic companies and share, (USD Million)
Global Personalized Medicine for Cancer revenue by player and market share 2019-2024, (USD Million)
Global Personalized Medicine for Cancer total market by Type, CAGR, 2019-2030, (USD Million)
Global Personalized Medicine for Cancer total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Personalized Medicine for Cancer market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, GlaxoSmithKline, Novartis, Sanofi, Pfizer, Amgen, Merck, Bristol-Myers Squibb and Ariad Pharmaceuticals (Takeda), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Personalized Medicine for Cancer market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Personalized Medicine for Cancer Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Personalized Medicine for Cancer Market, Segmentation by Type
    Immunotherapy
    Targeted Therapy
    Chemotherapy
    Hormone Therapy
    Others

Global Personalized Medicine for Cancer Market, Segmentation by Application
    Breast Cancer
    Blood Cancer
    Gastrointestinal Cancer
    Prostate Cancer
    Skin Cancer
    Lung Cancer
    Others

Companies Profiled:
    Bayer
    GlaxoSmithKline
    Novartis
    Sanofi
    Pfizer
    Amgen
    Merck
    Bristol-Myers Squibb
    Ariad Pharmaceuticals (Takeda)
    Eli Lilly
    Roche
    Boehringer Ingelheim
    Johnson and Johnson
    Teva Pharmaceuticals

Key Questions Answered
1. How big is the global Personalized Medicine for Cancer market?
2. What is the demand of the global Personalized Medicine for Cancer market?
3. What is the year over year growth of the global Personalized Medicine for Cancer market?
4. What is the total value of the global Personalized Medicine for Cancer market?
5. Who are the major players in the global Personalized Medicine for Cancer market?

Table of Contents

1 Supply Summary
    1.1 Personalized Medicine for Cancer Introduction
    1.2 World Personalized Medicine for Cancer Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Personalized Medicine for Cancer Total Market by Region (by Headquarter Location)
        1.3.1 World Personalized Medicine for Cancer Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Personalized Medicine for Cancer Market Size (2019-2030)
        1.3.3 China Personalized Medicine for Cancer Market Size (2019-2030)
        1.3.4 Europe Personalized Medicine for Cancer Market Size (2019-2030)
        1.3.5 Japan Personalized Medicine for Cancer Market Size (2019-2030)
        1.3.6 South Korea Personalized Medicine for Cancer Market Size (2019-2030)
        1.3.7 ASEAN Personalized Medicine for Cancer Market Size (2019-2030)
        1.3.8 India Personalized Medicine for Cancer Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Personalized Medicine for Cancer Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Personalized Medicine for Cancer Major Market Trends

2 Demand Summary
    2.1 World Personalized Medicine for Cancer Consumption Value (2019-2030)
    2.2 World Personalized Medicine for Cancer Consumption Value by Region
        2.2.1 World Personalized Medicine for Cancer Consumption Value by Region (2019-2024)
        2.2.2 World Personalized Medicine for Cancer Consumption Value Forecast by Region (2025-2030)
    2.3 United States Personalized Medicine for Cancer Consumption Value (2019-2030)
    2.4 China Personalized Medicine for Cancer Consumption Value (2019-2030)
    2.5 Europe Personalized Medicine for Cancer Consumption Value (2019-2030)
    2.6 Japan Personalized Medicine for Cancer Consumption Value (2019-2030)
    2.7 South Korea Personalized Medicine for Cancer Consumption Value (2019-2030)
    2.8 ASEAN Personalized Medicine for Cancer Consumption Value (2019-2030)
    2.9 India Personalized Medicine for Cancer Consumption Value (2019-2030)

3 World Personalized Medicine for Cancer Companies Competitive Analysis
    3.1 World Personalized Medicine for Cancer Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Personalized Medicine for Cancer Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Personalized Medicine for Cancer in 2023
        3.2.3 Global Concentration Ratios (CR8) for Personalized Medicine for Cancer in 2023
    3.3 Personalized Medicine for Cancer Company Evaluation Quadrant
    3.4 Personalized Medicine for Cancer Market: Overall Company Footprint Analysis
        3.4.1 Personalized Medicine for Cancer Market: Region Footprint
        3.4.2 Personalized Medicine for Cancer Market: Company Product Type Footprint
        3.4.3 Personalized Medicine for Cancer Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Personalized Medicine for Cancer Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Personalized Medicine for Cancer Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Personalized Medicine for Cancer Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Personalized Medicine for Cancer Consumption Value Comparison
        4.2.1 United States VS China: Personalized Medicine for Cancer Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Personalized Medicine for Cancer Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Personalized Medicine for Cancer Companies and Market Share, 2019-2024
        4.3.1 United States Based Personalized Medicine for Cancer Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Personalized Medicine for Cancer Revenue, (2019-2024)
    4.4 China Based Companies Personalized Medicine for Cancer Revenue and Market Share, 2019-2024
        4.4.1 China Based Personalized Medicine for Cancer Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Personalized Medicine for Cancer Revenue, (2019-2024)
    4.5 Rest of World Based Personalized Medicine for Cancer Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Personalized Medicine for Cancer Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Personalized Medicine for Cancer Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Personalized Medicine for Cancer Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Immunotherapy
        5.2.2 Targeted Therapy
        5.2.3 Chemotherapy
        5.2.4 Hormone Therapy
        5.2.5 Others
    5.3 Market Segment by Type
        5.3.1 World Personalized Medicine for Cancer Market Size by Type (2019-2024)
        5.3.2 World Personalized Medicine for Cancer Market Size by Type (2025-2030)
        5.3.3 World Personalized Medicine for Cancer Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Personalized Medicine for Cancer Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Breast Cancer
        6.2.2 Blood Cancer
        6.2.3 Gastrointestinal Cancer
        6.2.4 Prostate Cancer
        6.2.5 Prostate Cancer
        6.2.6 Lung Cancer
        6.2.7 Others
    6.3 Market Segment by Application
        6.3.1 World Personalized Medicine for Cancer Market Size by Application (2019-2024)
        6.3.2 World Personalized Medicine for Cancer Market Size by Application (2025-2030)
        6.3.3 World Personalized Medicine for Cancer Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Details
        7.1.2 Bayer Major Business
        7.1.3 Bayer Personalized Medicine for Cancer Product and Services
        7.1.4 Bayer Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Bayer Recent Developments/Updates
        7.1.6 Bayer Competitive Strengths & Weaknesses
    7.2 GlaxoSmithKline
        7.2.1 GlaxoSmithKline Details
        7.2.2 GlaxoSmithKline Major Business
        7.2.3 GlaxoSmithKline Personalized Medicine for Cancer Product and Services
        7.2.4 GlaxoSmithKline Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 GlaxoSmithKline Recent Developments/Updates
        7.2.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.3 Novartis
        7.3.1 Novartis Details
        7.3.2 Novartis Major Business
        7.3.3 Novartis Personalized Medicine for Cancer Product and Services
        7.3.4 Novartis Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Novartis Recent Developments/Updates
        7.3.6 Novartis Competitive Strengths & Weaknesses
    7.4 Sanofi
        7.4.1 Sanofi Details
        7.4.2 Sanofi Major Business
        7.4.3 Sanofi Personalized Medicine for Cancer Product and Services
        7.4.4 Sanofi Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Sanofi Recent Developments/Updates
        7.4.6 Sanofi Competitive Strengths & Weaknesses
    7.5 Pfizer
        7.5.1 Pfizer Details
        7.5.2 Pfizer Major Business
        7.5.3 Pfizer Personalized Medicine for Cancer Product and Services
        7.5.4 Pfizer Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Pfizer Recent Developments/Updates
        7.5.6 Pfizer Competitive Strengths & Weaknesses
    7.6 Amgen
        7.6.1 Amgen Details
        7.6.2 Amgen Major Business
        7.6.3 Amgen Personalized Medicine for Cancer Product and Services
        7.6.4 Amgen Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Amgen Recent Developments/Updates
        7.6.6 Amgen Competitive Strengths & Weaknesses
    7.7 Merck
        7.7.1 Merck Details
        7.7.2 Merck Major Business
        7.7.3 Merck Personalized Medicine for Cancer Product and Services
        7.7.4 Merck Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Merck Recent Developments/Updates
        7.7.6 Merck Competitive Strengths & Weaknesses
    7.8 Bristol-Myers Squibb
        7.8.1 Bristol-Myers Squibb Details
        7.8.2 Bristol-Myers Squibb Major Business
        7.8.3 Bristol-Myers Squibb Personalized Medicine for Cancer Product and Services
        7.8.4 Bristol-Myers Squibb Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Bristol-Myers Squibb Recent Developments/Updates
        7.8.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
    7.9 Ariad Pharmaceuticals (Takeda)
        7.9.1 Ariad Pharmaceuticals (Takeda) Details
        7.9.2 Ariad Pharmaceuticals (Takeda) Major Business
        7.9.3 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product and Services
        7.9.4 Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Ariad Pharmaceuticals (Takeda) Recent Developments/Updates
        7.9.6 Ariad Pharmaceuticals (Takeda) Competitive Strengths & Weaknesses
    7.10 Eli Lilly
        7.10.1 Eli Lilly Details
        7.10.2 Eli Lilly Major Business
        7.10.3 Eli Lilly Personalized Medicine for Cancer Product and Services
        7.10.4 Eli Lilly Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Eli Lilly Recent Developments/Updates
        7.10.6 Eli Lilly Competitive Strengths & Weaknesses
    7.11 Roche
        7.11.1 Roche Details
        7.11.2 Roche Major Business
        7.11.3 Roche Personalized Medicine for Cancer Product and Services
        7.11.4 Roche Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Roche Recent Developments/Updates
        7.11.6 Roche Competitive Strengths & Weaknesses
    7.12 Boehringer Ingelheim
        7.12.1 Boehringer Ingelheim Details
        7.12.2 Boehringer Ingelheim Major Business
        7.12.3 Boehringer Ingelheim Personalized Medicine for Cancer Product and Services
        7.12.4 Boehringer Ingelheim Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Boehringer Ingelheim Recent Developments/Updates
        7.12.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
    7.13 Johnson and Johnson
        7.13.1 Johnson and Johnson Details
        7.13.2 Johnson and Johnson Major Business
        7.13.3 Johnson and Johnson Personalized Medicine for Cancer Product and Services
        7.13.4 Johnson and Johnson Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Johnson and Johnson Recent Developments/Updates
        7.13.6 Johnson and Johnson Competitive Strengths & Weaknesses
    7.14 Teva Pharmaceuticals
        7.14.1 Teva Pharmaceuticals Details
        7.14.2 Teva Pharmaceuticals Major Business
        7.14.3 Teva Pharmaceuticals Personalized Medicine for Cancer Product and Services
        7.14.4 Teva Pharmaceuticals Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Teva Pharmaceuticals Recent Developments/Updates
        7.14.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Personalized Medicine for Cancer Industry Chain
    8.2 Personalized Medicine for Cancer Upstream Analysis
    8.3 Personalized Medicine for Cancer Midstream Analysis
    8.4 Personalized Medicine for Cancer Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Personalized Medicine for Cancer Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Personalized Medicine for Cancer Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Personalized Medicine for Cancer Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Personalized Medicine for Cancer Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Personalized Medicine for Cancer Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Personalized Medicine for Cancer Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Personalized Medicine for Cancer Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Personalized Medicine for Cancer Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Personalized Medicine for Cancer Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Personalized Medicine for Cancer Players in 2023
    Table 12. World Personalized Medicine for Cancer Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Personalized Medicine for Cancer Company Evaluation Quadrant
    Table 14. Head Office of Key Personalized Medicine for Cancer Player
    Table 15. Personalized Medicine for Cancer Market: Company Product Type Footprint
    Table 16. Personalized Medicine for Cancer Market: Company Product Application Footprint
    Table 17. Personalized Medicine for Cancer Mergers & Acquisitions Activity
    Table 18. United States VS China Personalized Medicine for Cancer Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Personalized Medicine for Cancer Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Personalized Medicine for Cancer Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Personalized Medicine for Cancer Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Personalized Medicine for Cancer Revenue Market Share (2019-2024)
    Table 23. China Based Personalized Medicine for Cancer Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Personalized Medicine for Cancer Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Personalized Medicine for Cancer Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Personalized Medicine for Cancer Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Personalized Medicine for Cancer Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Personalized Medicine for Cancer Revenue Market Share (2019-2024)
    Table 29. World Personalized Medicine for Cancer Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Personalized Medicine for Cancer Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Personalized Medicine for Cancer Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Personalized Medicine for Cancer Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Personalized Medicine for Cancer Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Personalized Medicine for Cancer Market Size by Application (2025-2030) & (USD Million)
    Table 35. Bayer Basic Information, Area Served and Competitors
    Table 36. Bayer Major Business
    Table 37. Bayer Personalized Medicine for Cancer Product and Services
    Table 38. Bayer Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Bayer Recent Developments/Updates
    Table 40. Bayer Competitive Strengths & Weaknesses
    Table 41. GlaxoSmithKline Basic Information, Area Served and Competitors
    Table 42. GlaxoSmithKline Major Business
    Table 43. GlaxoSmithKline Personalized Medicine for Cancer Product and Services
    Table 44. GlaxoSmithKline Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. GlaxoSmithKline Recent Developments/Updates
    Table 46. GlaxoSmithKline Competitive Strengths & Weaknesses
    Table 47. Novartis Basic Information, Area Served and Competitors
    Table 48. Novartis Major Business
    Table 49. Novartis Personalized Medicine for Cancer Product and Services
    Table 50. Novartis Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Novartis Recent Developments/Updates
    Table 52. Novartis Competitive Strengths & Weaknesses
    Table 53. Sanofi Basic Information, Area Served and Competitors
    Table 54. Sanofi Major Business
    Table 55. Sanofi Personalized Medicine for Cancer Product and Services
    Table 56. Sanofi Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Sanofi Recent Developments/Updates
    Table 58. Sanofi Competitive Strengths & Weaknesses
    Table 59. Pfizer Basic Information, Area Served and Competitors
    Table 60. Pfizer Major Business
    Table 61. Pfizer Personalized Medicine for Cancer Product and Services
    Table 62. Pfizer Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Pfizer Recent Developments/Updates
    Table 64. Pfizer Competitive Strengths & Weaknesses
    Table 65. Amgen Basic Information, Area Served and Competitors
    Table 66. Amgen Major Business
    Table 67. Amgen Personalized Medicine for Cancer Product and Services
    Table 68. Amgen Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Amgen Recent Developments/Updates
    Table 70. Amgen Competitive Strengths & Weaknesses
    Table 71. Merck Basic Information, Area Served and Competitors
    Table 72. Merck Major Business
    Table 73. Merck Personalized Medicine for Cancer Product and Services
    Table 74. Merck Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Merck Recent Developments/Updates
    Table 76. Merck Competitive Strengths & Weaknesses
    Table 77. Bristol-Myers Squibb Basic Information, Area Served and Competitors
    Table 78. Bristol-Myers Squibb Major Business
    Table 79. Bristol-Myers Squibb Personalized Medicine for Cancer Product and Services
    Table 80. Bristol-Myers Squibb Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Bristol-Myers Squibb Recent Developments/Updates
    Table 82. Bristol-Myers Squibb Competitive Strengths & Weaknesses
    Table 83. Ariad Pharmaceuticals (Takeda) Basic Information, Area Served and Competitors
    Table 84. Ariad Pharmaceuticals (Takeda) Major Business
    Table 85. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Product and Services
    Table 86. Ariad Pharmaceuticals (Takeda) Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Ariad Pharmaceuticals (Takeda) Recent Developments/Updates
    Table 88. Ariad Pharmaceuticals (Takeda) Competitive Strengths & Weaknesses
    Table 89. Eli Lilly Basic Information, Area Served and Competitors
    Table 90. Eli Lilly Major Business
    Table 91. Eli Lilly Personalized Medicine for Cancer Product and Services
    Table 92. Eli Lilly Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Eli Lilly Recent Developments/Updates
    Table 94. Eli Lilly Competitive Strengths & Weaknesses
    Table 95. Roche Basic Information, Area Served and Competitors
    Table 96. Roche Major Business
    Table 97. Roche Personalized Medicine for Cancer Product and Services
    Table 98. Roche Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Roche Recent Developments/Updates
    Table 100. Roche Competitive Strengths & Weaknesses
    Table 101. Boehringer Ingelheim Basic Information, Area Served and Competitors
    Table 102. Boehringer Ingelheim Major Business
    Table 103. Boehringer Ingelheim Personalized Medicine for Cancer Product and Services
    Table 104. Boehringer Ingelheim Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Boehringer Ingelheim Recent Developments/Updates
    Table 106. Boehringer Ingelheim Competitive Strengths & Weaknesses
    Table 107. Johnson and Johnson Basic Information, Area Served and Competitors
    Table 108. Johnson and Johnson Major Business
    Table 109. Johnson and Johnson Personalized Medicine for Cancer Product and Services
    Table 110. Johnson and Johnson Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Johnson and Johnson Recent Developments/Updates
    Table 112. Teva Pharmaceuticals Basic Information, Area Served and Competitors
    Table 113. Teva Pharmaceuticals Major Business
    Table 114. Teva Pharmaceuticals Personalized Medicine for Cancer Product and Services
    Table 115. Teva Pharmaceuticals Personalized Medicine for Cancer Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 116. Global Key Players of Personalized Medicine for Cancer Upstream (Raw Materials)
    Table 117. Personalized Medicine for Cancer Typical Customers
List of Figure
    Figure 1. Personalized Medicine for Cancer Picture
    Figure 2. World Personalized Medicine for Cancer Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Personalized Medicine for Cancer Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Personalized Medicine for Cancer Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Personalized Medicine for Cancer Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Personalized Medicine for Cancer Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Personalized Medicine for Cancer Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Personalized Medicine for Cancer Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Personalized Medicine for Cancer Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Personalized Medicine for Cancer Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Personalized Medicine for Cancer Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Personalized Medicine for Cancer Revenue (2019-2030) & (USD Million)
    Figure 13. Personalized Medicine for Cancer Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Personalized Medicine for Cancer Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Personalized Medicine for Cancer Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Personalized Medicine for Cancer by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Personalized Medicine for Cancer Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Personalized Medicine for Cancer Markets in 2023
    Figure 27. United States VS China: Personalized Medicine for Cancer Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Personalized Medicine for Cancer Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Personalized Medicine for Cancer Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Personalized Medicine for Cancer Market Size Market Share by Type in 2023
    Figure 31. Immunotherapy
    Figure 32. Targeted Therapy
    Figure 33. Chemotherapy
    Figure 34. Hormone Therapy
    Figure 35. Others
    Figure 36. World Personalized Medicine for Cancer Market Size Market Share by Type (2019-2030)
    Figure 37. World Personalized Medicine for Cancer Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 38. World Personalized Medicine for Cancer Market Size Market Share by Application in 2023
    Figure 39. Breast Cancer
    Figure 40. Blood Cancer
    Figure 41. Gastrointestinal Cancer
    Figure 42. Prostate Cancer
    Figure 43. Skin Cancer
    Figure 44. Lung Cancer
    Figure 45. Others
    Figure 46. Personalized Medicine for Cancer Industrial Chain
    Figure 47. Methodology
    Figure 48. Research Process and Data Source

Companies Mentioned

Bayer
GlaxoSmithKline
Novartis
Sanofi
Pfizer
Amgen
Merck
Bristol-Myers Squibb
Ariad Pharmaceuticals (Takeda)
Eli Lilly
Roche
Boehringer Ingelheim
Johnson and Johnson
Teva Pharmaceuticals